Thomas Hudson
Chief Tech/Sci/R&D Officer at ABBVIE INC.
Net worth: 20 M $ as of 2024-03-30
Profile
Founder of McGill University & Génome Québec Innovation Centre, Thomas J. Hudson is Chief Scientific Officer, Senior VP-R&D at AbbVie, Inc. He is also Scientific Director at P3G Consortium and Professor at the University of Toronto. In the past he was President & Scientific Director at Ontario Institute for Cancer Research, Assistant Director-Center for Genome Research at Whitehead Institute for Biomedical Research and Director at McGill University & Génome Québec Innovation Centre.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ABBVIE, INC.
0.01% | 2024-02-27 | 107,267 ( 0.01% ) | 20 M $ | 2024-03-30 |
Thomas Hudson active positions
| Companies | Position | Start |
|---|---|---|
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 2019-06-30 |
| University of Toronto | Corporate Officer/Principal | 2006-12-31 |
| P3G Consortium | Chief Tech/Sci/R&D Officer | - |
Former positions of Thomas Hudson
| Companies | Position | End |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | 2015-12-31 |
| McGill University & Génome Québec Innovation Centre | Founder | 2010-12-31 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2000-12-31 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Training of Thomas Hudson
| University of Montréal | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Private companies | 4 |
|---|---|
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
| P3G Consortium |
- Stock Market
- Insiders
- Thomas Hudson
